High Valuations Hide Risks for Investors, Warns Ex-Goldman Sachs Strategist
Ex-Goldman Sachs strategist Abby Joseph Cohen warns elevated equity valuations obscure risks, signaling potential correction if earnings fail to meet expectations.
Ex-Goldman Sachs strategist Abby Joseph Cohen warns elevated equity valuations obscure risks, signaling potential correction if earnings fail to meet expectations.
Mercedes-Benz and GIC’s backing of Momenta’s IPO underscores autonomous driving’s investment appeal and may ripple across Chinese tech stocks and German auto…
Shares of Morgan Stanley and Goldman Sachs fell sharply after reports suggested OpenAI's IPO could be delayed, impacting the banks' underwriting fee…
Apple's next-generation Touch MacBook will debut with M5 Pro and Max chips, positioning the company to lead the premium laptop market as…
Castel Group’s internal feud after heirs were removed from its historic wine unit lifted Pernod Ricard shares and pressured the CAC 40,…
Securitize, a BlackRock-backed tokenization firm, aims to raise $400 million through a SPAC merger and list on the NYSE next week, signaling…
Kalshi speculators slash 2026 IPO odds for OpenAI to one-in-three, pushing the expected announcement to early 2027 amid mounting partnership and market…
OpenAI's 2027 IPO plan, after Anthropic's upcoming public debut, reshapes AI investment landscape, impacting Microsoft's stake, technology IPOs, and sector valuations.
A global selloff in technology and chipmaker stocks pressured U.S. indexes, with the Nasdaq leading declines as investors reassessed AI valuations.
Amgen’s Tavneos faces EU withdrawal after regulators question clinical data integrity, threatening a growth driver and pressuring AMGN shares.
Goldman Sachs reports that despite a sharp rebound in 2026 U.S. IPO issuance, the market shows no signs of dot-com-era speculative mania,…
Goldman Sachs sees buying opportunities in Big Tech like Apple and Microsoft as semiconductor volatility hits Nvidia and other chip stocks, recommending…